IRIS
FORMICA, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.410
AS - Asia 2.475
EU - Europa 1.802
SA - Sud America 500
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 24.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.339
SG - Singapore 1.296
CN - Cina 445
BR - Brasile 439
IT - Italia 374
HK - Hong Kong 340
DE - Germania 240
UA - Ucraina 235
IE - Irlanda 217
RU - Federazione Russa 184
VN - Vietnam 130
GB - Regno Unito 102
FR - Francia 91
SE - Svezia 85
PL - Polonia 80
FI - Finlandia 78
KR - Corea 62
IN - India 36
ID - Indonesia 34
CA - Canada 33
AR - Argentina 30
NL - Olanda 30
BD - Bangladesh 26
JP - Giappone 26
MX - Messico 26
AT - Austria 20
BE - Belgio 17
ES - Italia 13
EC - Ecuador 10
IQ - Iraq 10
TR - Turchia 10
ZA - Sudafrica 10
EU - Europa 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 6
LT - Lituania 6
PK - Pakistan 6
SA - Arabia Saudita 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
JM - Giamaica 4
KG - Kirghizistan 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
TH - Thailandia 4
TN - Tunisia 4
CL - Cile 3
CR - Costa Rica 3
NP - Nepal 3
QA - Qatar 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
MN - Mongolia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 24.228
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.248
Wilmington 4.706
Houston 4.625
Singapore 621
Fairfield 573
Ashburn 367
Chandler 342
Ann Arbor 336
Hong Kong 336
Seattle 260
Beijing 247
Cambridge 215
Jacksonville 213
Dublin 203
Medford 162
Dallas 140
Rome 140
New York 131
Santa Clara 114
Los Angeles 96
Dearborn 89
The Dalles 88
Engelhard 85
Lawrence 72
Menlo Park 67
Kraków 64
Buffalo 60
Council Bluffs 56
Ho Chi Minh City 52
San Diego 46
Milan 37
Moscow 36
Saint Petersburg 35
Redondo Beach 33
Zhengzhou 33
São Paulo 31
Chicago 27
Hanoi 25
Jakarta 25
Falls Church 24
Tokyo 21
Boardman 20
Mülheim 19
London 18
Nuremberg 18
Brussels 17
Montreal 15
Warsaw 15
Lappeenranta 14
Rio de Janeiro 14
Belo Horizonte 13
Brooklyn 13
Chennai 13
Helsinki 13
Mexico City 13
Cagliari 12
Porto Alegre 11
Salt Lake City 11
San Francisco 11
Stockholm 11
Boston 10
Detroit 10
Frankfurt am Main 10
Munich 10
Nanjing 10
Norwalk 10
Seoul 10
Turin 10
Hangzhou 9
Hefei 9
Orem 9
Phoenix 9
Redwood City 9
Vienna 9
Atlanta 8
Bologna 8
Brasília 8
Denver 8
Kunming 8
Palo Alto 8
Curitiba 7
Mannheim 7
Shanghai 7
Sorocaba 7
Vancouver 7
Amsterdam 6
Charlotte 6
Creede 6
Elk Grove Village 6
Goiânia 6
Guangzhou 6
Johannesburg 6
Manchester 6
University Park 6
Verona 6
Bexley 5
Campinas 5
Columbus 5
Fort Worth 5
Haiphong 5
Totale 20.654
Salva come PNG Salva come JPEG
Nome #
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 508
Preclinical studies on detection of circulating melanoma cells in patients: Telomerase as a recognition marker of malignancy 480
Drug-induced increase of carcinoembryonic antigen expression in cancer cells 473
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 456
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 453
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 451
Biological and predictive role of ERCC1 polymorphisms in cancer 448
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 447
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 444
Immune reaction and colorectal cancer: friends or foes? 440
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 437
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 436
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 433
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 431
Prognostic value of glycated hemoglobin in colorectal cancer 431
Thromboembolic events in patients treated with anti-angiogenic drugs 420
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 419
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 417
Family history of cancer in patients with gastric cancer 416
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 413
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 411
Insulinemia and the risk of breast cancer and its relapse 405
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 402
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 399
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 395
CD26: a multi-purpose pharmacological target 393
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 390
Up-regulation of carcinoembryonic antigen (CEA) expression by staurosporine in circulating colon cancer cells 388
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 388
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 387
Kallikrein-related peptidases targeted therapies in prostate cancer: Perspectives and challenges 381
Targeted therapy in first line treatment of RAS wild type colorectal cancer 377
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 373
Caregiver distress in the early phases of cancer 370
A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes 370
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 368
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches 367
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) 364
Prognostic significance of serum adipokine levels in colorectal cancer patients 363
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 357
Non-steroidal anti-inflammatory drugs in cancer prevention and therapy 352
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 345
Percutaneous combined therapy for painful sternal metastases: a radiofrequency thermal ablation (RFTA) and cementoplasty protocol 337
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 337
Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer 331
A novel K-ras mutation in colorectal cancer. A case report and literature review 330
Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy 313
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 306
Chemotherapy in patients with hereditary angioedema 306
Case report of a patient with breast metastasis from gastric cancer treated with paclitaxel and ramucirumab plus regional hyperthermia 302
Cancer patients in the emergency department: A "nightmare" that might become a virtuous clinical pathway 278
Histotype influences emergency presentation and prognosis in colon cancer surgery 222
Relevance of computed tomography and magnetic resonance imaging for penile metastasis after prostatectomy: uncommon case report and brief review of the literature 207
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2 187
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors 161
A nomogram to predict neutropenia in metastatic pancreatic cancer patients treated with gemcitabine/nab-paclitaxel 156
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt 120
Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer 117
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors 103
Irinotecan or oxaliplatin: which is the first move for the mate? 99
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 98
Lymph node-only metastatic gastric/gastroesophageal junction cancer and efficacy of immunotherapy 96
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 96
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study 92
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice? 90
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 90
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset 88
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 83
The effects of association of topical polydatin improves the preemptive systemic treatment on EGFR inhibitors cutaneous adverse reactions 83
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma 82
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 79
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 78
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 73
Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and age 72
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ?BRAF BeCool? study 71
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview 71
Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study 71
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 65
Role of systemic inflammation and CD45RO+CD8+ cells in metastatic colorectal cancer = Ruolo dell’infiammazione e delle cellule CD45RO+CD8+ nei tumori colorettali metastatici 65
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy [3] 64
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 64
Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: Report of a case 62
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 62
Role of systemic inflammation and CD45RO+CD8+ cells in metastatic colorectal cancer = Ruolo dell’infiammazione e delle cellule CD45RO+CD8+ nei tumori colorettali metastatici 61
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 58
Issues and promises of bevacizumab in prostate cancer treatment 58
Adjuvant therapy for very young women with breast cancer: Response according to biologic and endocrine features 57
Gender differences in cancer-associated venous thromboembolism 55
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 54
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 54
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 51
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 50
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram 48
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 47
Antioxidant activity of phenolic extracts from different cultivars of Italian onion (Allium cepa) and relative human immune cell proliferative induction 45
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment 44
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 44
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer 44
Obesity and common pathways of cancer and cardiovascular disease 42
5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: Should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma 41
Totale 24.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.562 0 0 0 0 0 419 464 350 78 86 115 50
2021/2022855 32 81 38 48 44 70 75 65 67 86 49 200
2022/2023936 87 73 21 113 116 228 73 56 82 10 42 35
2023/2024567 40 16 36 20 33 103 176 51 7 4 5 76
2024/20252.512 56 488 207 125 33 183 165 167 444 255 204 185
2025/20262.266 372 281 637 392 411 173 0 0 0 0 0 0
Totale 24.650